Compare · head to head
Eisai vs Jeil Pharma
Jeil Pharma ranks higher overall — 360 rank 73 vs 70.
Eisai leads on Value (81 vs 61) and Safety (60 vs 42). Jeil Pharma leads on Quality (62 vs 39) and Growth (53 vs 39). The two are close on Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Japan | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | X-Large | Small |
| ISIN | JP3160400002 | KR7002620003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | — | |
| Ranks | ||
| 360 | 70 | 73 |
| Value | 81 | 61 |
| Quality | 39 | 62 |
| Growth | 39 | 53 |
| Safety | 60 | 42 |
| Sentiment | 52 | 56 |
| Quality details | ||
| Profitability | 30 | 74 |
| Cash Truth | 48 | 50 |
Eisai vs Towa PharmaceuticalEisai vs JW PharmaceuticalEisai vs Jeil PharmaceuticalEisai vs Lotus PharmaceuticalAdd a third stock →
Full analyses: Eisai · Jeil Pharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100